Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
China Biologic Reports Financial Results for the Second Quarter of 2019 2019-08-06 04:30
New Drug for Diabetes-Induced Vision Loss TGA-Approved for Australian Patients 2019-08-05 20:00
I-Mab Biopharma and TRACON Pharmaceuticals Announce Dosing of the First Patient in a Phase 1 Trial of the CD73 Antibody TJD5 in the U.S. in Patients with Advanced Solid Tumors 2019-08-01 20:06
111 to Announce Second Quarter 2019 Unaudited Financial Results on August 15, 2019 2019-08-01 20:00
New Texas Imaging Center Utilizing United Imaging Equipment, Demonstrating the Innovation of Cutting-Edge Portfolio in the U.S. 2019-08-01 20:00
Samsung BioLogics and UCB Sign Third Drug Manufacturing Deal 2019-07-31 19:00
GC Pharma Reports Q2 2019 Results 2019-07-30 22:31
Alvotech and Cipla Gulf Enter Into a Partnership for the Commercialization of Key Biosimilar in Select Emerging Markets 2019-07-29 12:00
China Biologic Products to Report Second Quarter 2019 Financial Results 2019-07-27 04:30
Volition Announces Exercise of Warrant to Purchase $4.8 Million in Common Stock 2019-07-25 04:05
NanoCellect Biomedical Expands Distribution to Australia and New Zealand 2019-07-24 21:57
111 Signs Strategic Cooperation with Harbin Pharmaceutical Group 2019-07-24 20:00
Shanghai Concord Medical Cancer Center has Accepted Medical Insurance Settlement from Patients from certain Yangtze River Delta Regions 2019-07-23 18:03
CStone receives approval in China to initiate ivosidenib Phase I bridging registrational study for the treatment of IDH1 mutant relapsed or refractory AML 2019-07-22 12:17
Yuyu Pharma Receives Recognition for Outstanding Company Culture in Korea 2019-07-17 21:00
AirXpanders® Announces Reduction in Force and Plan to Cease Operations 2019-07-17 07:17
AirXpanders® Receives FDA 510(k) Clearance for a Smooth Shell Version of the AeroForm® Tissue Expander System 2019-07-15 09:17
Yuyu Pharma held the campaign for enhancing corporate transparency 2019-07-11 16:43
MacroGenics and I-Mab Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Enoblituzumab in Greater China 2019-07-11 04:01
VolitionRx Limited Awarded an Additional $1.4 Million in Non-Dilutive Funding 2019-07-10 20:30
1 218 219 220 221 222 431